Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Aug 26, 2022; 10(24): 8788-8796
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8788
Table 1 Diagnostic criteria for type 2 autoimmune pancreatitis

Level 1
Level 2
ClinicalA response to a steroid trial with rapid (< 2 wk) radiologically demonstrable resolution or marked improvement in manifestationsClinically diagnosed inflammatory bowel diseases
Parenchymal imagingDiffuse enlargement with delayed enhancementSegmental/focal enlargement with delayed enhancement
Ductal imaging Long (> 1/3 length of the main pancreatic duct) or multiple strictures without marked upstream dilatationSegmental/focal narrowing without marked upstream dilatation (duct size, < 5 mm)
HistologyGranulocytic infiltration of duct wall, granulocytic epithelial lesions with or without granulocytic acinar inflammation and; absent or scant (0-10 cells/HPF) IgG4-positive cellsGranulocytic and lymphoplasmacytic acinar infiltrate and; again absent or scant (0-10 cells/HPF) IgG4-positive cells
Table 2 Diagnosis of definitive and probable type 2 autoimmune pancreatitis

Imaging evidence
Collateral evidence
ProbableLevel 1 or 2Level 2 histology OR; IBD and response to steroids
DefinitiveLevel 1 or 2Level 1 histology OR; IBD, level 2 histology and response to steroids
Table 3 Case summaries

Case 1
Case 2
Case 3
GenderMaleMaleFemale
Age at IBD diagnosis545646
Extent of UC (Montreal)A3 E3A3 E3A3 E3
Extraintestinal manifestationsRecurrent mouth ulcerationNilNil
SurgeryColectomyColectomyNil
Occurrence of cancersNilNilNil
Age at AIP diagnosis556246
AIP typeProbable type 2Probable type 2Definitive type 2
Other organ involvementNilNilNil
PresentationObstructive jaundiceObstructive jaundiceAcute pancreatitis
IBD or AIP firstIBDIBDIBD
TreatmentCorticosteroids CorticosteroidsCorticosteroids
RelapseYes (spontaneous resolution)NilYes (treated with corticosteroids)
Evolution (diabetes, exocrine insufficiency)DiabetesDiabetes, Exocrine insufficiencyNil